2021
DOI: 10.1002/ange.202015913
|View full text |Cite
|
Sign up to set email alerts
|

Robust Packing of a Self‐Assembling Iridium Complex via Endocytic Trafficking for Long‐Term Lysosome Tracking

Abstract: Figure 4. a) Fluorescent images of self-assembled Irpc (green) and DAPI (blue) in a HeLa cell under fed (left) and starved conditions (right). b) Time-lapse SIM images of a HeLa cell treated with Irpc (2 mM/20 min) co-stained with MitoTracker Deepred.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 26 publications
(27 reference statements)
0
1
0
Order By: Relevance
“…25,26 Capitalizing on these promising properties, iridium(III) coordination complexes have been investigated as two-photon near-infrared excited photosensitizers for photodynamic therapy, [27][28][29][30][31] luminescent probes for the detection of specific cellular processes, [32][33][34][35][36] or cellular dyes. 37,38 However, due to the poor tumor selectivity of the molecular iridium(III) complexes upon intravenous injection into the bloodstream, these compounds could only find an application by local intratumoral injection, thus limiting their application. To overcome this drawback as well as reduce the potential dark toxicity, these metal complexes could be incorporated into a tumor-targeting nanoplatform, presenting a selective and therapeutically enhanced effect.…”
Section: Introductionmentioning
confidence: 99%
“…25,26 Capitalizing on these promising properties, iridium(III) coordination complexes have been investigated as two-photon near-infrared excited photosensitizers for photodynamic therapy, [27][28][29][30][31] luminescent probes for the detection of specific cellular processes, [32][33][34][35][36] or cellular dyes. 37,38 However, due to the poor tumor selectivity of the molecular iridium(III) complexes upon intravenous injection into the bloodstream, these compounds could only find an application by local intratumoral injection, thus limiting their application. To overcome this drawback as well as reduce the potential dark toxicity, these metal complexes could be incorporated into a tumor-targeting nanoplatform, presenting a selective and therapeutically enhanced effect.…”
Section: Introductionmentioning
confidence: 99%